Erin McGuinness

News

Opioid Overdoses Related to Neurocognitive Impairment

09/10/2021

There is an association between non-fatal opioid overdoses and brain injuries/neurocognitive impairments, according to a systematic review summarizing research on opioid-related overdose.

There is an association between...

09/10/2021

Psych Congress Network

News

Lipid-Specific IgM Oligoclonal Bands Can Predict Aggressive Multiple Sclerosis Early

08/11/2021

Erin McGuinness ;

Intrathecal immunoglobulin M synthesis (ITMS), a biomarker for poor prognosis in patients with multiple sclerosis (MS), can predict aggressive MS at disease onset when detected by lipid-specific IgM oligoclonal bands (LS-OCMBs), according to...

Intrathecal immunoglobulin M...

08/11/2021

Neurology

News

Studies Show Success with Cariprazine as Adjunctive Treatment of Major Depressive Disorder

11/10/2021

Erin McGuinness ;

AbbVie announced positive results from a Phase 3 study in which cariprazine (VRAYLAR) met the primary endpoint as an adjunctive treatment of major depressive disorder.

AbbVie announced positive...

11/10/2021

Psych Congress Network

News

NAMI Hosting REIMAGINE Week of Action to Advocate for Improvement of Crisis Services

11/15/2021

Erin McGuinness ;

The National Alliance on Mental Illness is hosting a week of virtual events November 15-19 aims to advocate for the improvement of crisis services.

The National Alliance on Mental...

11/15/2021

Psych Congress Network

News

Physical Activity Associated With Reduced Mortality Rate for Patients With Parkinson Disease

11/16/2021

Erin McGuinness ;

Physical activity is associated with reduced all-cause mortality in patients with Parkinson disease (PD), according to new findings published in JAMA Neurology.

Physical activity is associated...

11/16/2021

Neurology

News

Internet-Delivered Mindfulness-Based Intervention Beneficial for Patients With MS and Depression

02/25/2022

Erin McGuinness ;

For patients with multiple sclerosis (MS), internet-delivered mindfulness-based intervention (MBI) can improve symptoms of depression, according to recent study findings.

For patients with multiple...

02/25/2022

Neurology

News

Lumateperone Safe, Effective for Improving Depression Symptoms in Patients with Bipolar Disorders

09/27/2021

Erin McGuinness ;

Lumateperone can safely improve symptoms for patients with bipolar I or bipolar II disorder experiencing major depressive episodes, according to new research published in the American Journal of Psychiatry.

Lumateperone can safely improve...

09/27/2021

Psych Congress Network

News

Ocrelizumab Effective at Controlling Relapse in Patients with Multiple Sclerosis

08/05/2021

Erin McGuinness ;

Ocrelizumab is an effective treatment option to control relapse risk and disability worsening in patients with multiple sclerosis (MS), according to recent findings published in BMJ Neurology Open.

Ocrelizumab is an effective...

08/05/2021

Neurology

Once-Monthly LAIs May Lower Schizophrenia Hospitalization Rates

10/29/2021

Erin McGuinness ;

Once-monthly LAIs showed lower rates of hospitalization when compared to daily oral injectables and biweekly LAIs, according to new research shown in a poster presentation at Psych Congress.

Once-monthly LAIs showed lower...

10/29/2021

Psych Congress Network

News

REM Sleep Without Atonia Variables May Predict Parkinson Disease Diagnosis

09/29/2021

Erin McGuinness ;

Increased REM sleep without atonia variable subscores are present in prediagnostic Parkinson disease, independent of REM sleep behavior disorder status, according to findings presented at MDS Virtual Congress 2021.

Increased REM sleep without...

09/29/2021

Neurology